The nuclear factor-jB (NF-jB) signalling pathway serves a crucial role in regulating the transcriptional responses of physiological processes that include cell division, cell survival, differentiation, immunity and inflammation. Here we outline studies using mouse models in which the core components of the NF-jB pathway, namely the IjB kinase subunits (IKKa, IKKb and NEMO), the IjB proteins (IjBa, IjBb, IjBe and Bcl-3) and the five NF-jB transcription factors (NF-jB1, NF-jB2, c-Rel, RelA and RelB), have been genetically manipulated using transgenic and knockout technology.
Introduction
Since its discovery 20 years ago, information about the regulation and function of the nuclear factor-kB (NF-kB) signalling pathway has increased exponentially. It is a ubiquitous pathway, designed to rapidly reprogram gene expression in response to diverse stimuli. In contrast to most signalling pathways, the pre-existing NF-kB transcriptional mediators reside in the cytoplasm and are rapidly activated by a mechanism of nuclear shuttling involving a kinase cascade that can be engaged by a wide array of external stimuli, in particular signals associated with stress that include microbial components, growth factors, cytokines and inflammatory mediators (see Pahl, 1999; Gilmore, 2006; Scheidereit, 2006) .
The breadth of signals able to activate the NF-kB pathway underscores its importance in regulating physiological functions as diverse as cell division, cell survival, differentiation, immunity and perhaps even learning and memory under normal circumstances and in various diseases states. Therefore, it is not surprising that a range of mouse genetic strategies have been adopted to unravel the functions of the core components of the NF-kB signalling pathway. The purpose of this review is to catalogue the roles of the different NF-kB primary signalling modules, namely the IKKs, IkBs and transcription factors, as revealed through the use of knockout and transgenic mouse models. Building on a previous article in this journal and due to the overwhelming body of information that is now available, this review in certain instances is selective in its focus, describing findings arising from particular models or certain cell types that best illustrate a particular function.
Genetic dissection of the NF-jB pathway: the many and varied approaches
Since the first installment of this review was published 7 years ago , there has been a veritable explosion of information describing the phenotype of mice in which the NF-kB pathway has been genetically manipulated. The catalogue of strategies used to dissect NF-kB signalling include ubiquitous and tissue-specific transgene expression of dominant-negative or constitutively active versions of IKK and IkB proteins, systemic knockouts for single or multiple transcription factors, IKK and IkB proteins, inducible or tissue-specific conditional knockouts using Cre/loxP recombination, gene knock-ins to examine particular aspects of NF-kB pathway function in the context of normal regulation and kB-site reporter mice to study NF-kB activity. In interpreting the findings from all of these models, it is important to consider a number of issues. First, redundancy exists throughout the pathway, in particular among the transcriptional mediators and this can vary in a cell-type and developmental stagespecific manner. Second, embryonic lethality resulting from an absence of IKKb or RelA function has made certain questions difficult to address. This has to some extent been overcome by using conditional knockouts, although this approach is limited by the efficiency and availability of appropriate tissue-specific Cre transgenic mouse lines. Third, crosstalk exists between the canonical and alternate signalling pathways at the level of both IKKs and transcription factors. Fourth, the disruption of other key intracellular signalling pathways through loss of NF-kB function, as illustrated by perturbation of Tpl2/extracellular signal-regulated kinase (ERK) signalling in nfkb1 À/À mice, can complicate the interpretation of genetic models. Finally, both IKKa and IKKb, in addition to activating the NF-kB pathway through phosphorylation of IkBs, p105 and p100, also appear to phosphorylate targets that are independent of the NF-kB pathway (see Scheidereit, 2006) . The phenotypes that arise in the various knockout or transgenic mouse models for IKK, NF-kB or IkB proteins are summarized in Tables 1, 2 and 3, respectively.
NF-jB transcription factors
The transcription factors NF-kB p52, NF-kB p52, RelA, c-Rel and RelB can generally function either as homodimers or heterodimers: to date, 16 different NF-kB dimer combinations have been described. Although the absence of a particular NF-kB protein is generally not accompanied by compensatory changes in the expression of other family members, with the interactions between NF-kB proteins that result from heterodimer formation or in some instances transcriptional crossregulation, removing one of these transcription factors inevitably alters the balance among the remaining dimers within a cell.
NF-kB p50/p105
The p50 subunit of NF-kB, encoded by the nfkb1 gene, is derived by proteolysis from the N-terminal half of the p105 precursor. p105 also serves as a scaffold for Tpl2 and can function as a cis-acting IkB protein through the action of its C-terminal ankyrin domain.
nfkb1
À/À mice. Despite its ubiquitous expression, the absence of p105 is tolerated during embryonic development and is compatible with neonatal and adult viability (Sha et al., 1995) . In addition to a mild learning deficit (Meffert and Baltimore, 2005) , loss of NF-kB p50/p105 function is associated with defects in stress responses, Sha et al. (1995) , Grumont et al. (1998) , Snapper et al. (1996) , Cariappa et al. (2000) , Pohl et al. (2002) Th2 differentiation is impaired Das et al. (2001) 
No
Complex inflammatory phenotype and hematopoietic abnormalities Burkly et al. (1995) , Weih et al. (1995) Defects in secondary lymphoid organ structure and germinal center formation No Gastric hyperplasia, hyperkeratosis in the heart, spleen and thymic atrophy, enlarged lymph nodes, lymphocytic infiltrates of various tissues and granulocytosis Ishikawa et al. (1997) Mice lacking multiple subunits nfkb1
No Growth retarded and craniofacial abnormalities due to osteopetrosis Franzoso et al. (1997b) , Iotsova et al. (1997) Severe defects in secondary lymphoid organ development Grossmann et al. (1999 Grossmann et al. ( , 2000 T cells exhibit a cell-cycle block early in G1 resulting from a failure to undergo c-Myc-dependent growth Grumont et al. (2004) rela À/À c-rel
Neonatal E18 embryos exhibit multiple epidermal defects that include a failure to form specific hair types, disorganized basal Gugasyan et al. (2004) Knockout and transgenic models for NF-jB pathway S Gerondakis et al plus impaired innate and adaptive immune function. Ascribing the defects observed in nfkb1 À/À mice solely to a loss of p50 function is complicated by the finding that approximately one-third of the p105 pool acts as a scaffold for the MEK kinase Tpl2 (Beinke and Ley, 2004) . In the absence of p105, very little Tpl2 can be detected in cells owing to its rapid degradation (Beinke and Ley, 2004) . As a consequence, nfkb1 À/À cells, which in effect are also deficient in Tpl2, have defects in two major signalling pathways. This compound signalling defect is best understood in nfkb1 À/À macrophages, which, in addition to lacking dimers that contain p50, fail to activate the ERK mitogen-activated protein kinase pathway in response to diverse microbial signals (Waterfield et al., 2003; Banerjee et al., 2006) . To date, the expression pattern of Tpl2 remains poorly defined, so caution needs to be exercised in concluding which of the phenotypic defects observed in mice lacking p105 are the result of a loss of p50 function, Tpl2 activity or a combination of both.
In the B-lymphoid lineage, marginal zone and CD5 þ peritoneal B-cell populations are reduced in nfkb1 À/À mice (Cariappa et al., 2000; Pohl et al., 2002) . Although follicular B-cell numbers are normal, this population turns over more rapidly 'in vivo' (Grumont et al., 1998) , a phenotype linked to an accelerated rate of quiescent B-cell apoptosis (Grumont et al., 1998) . Although the tumor necrosis factor-receptor (TNF-R) superfamily ligand BAFF has been shown to promote the survival of follicular B cells by inducing p52 expression (Claudio Pancreatic islets Impaired glucose tolerance and mild diabetes Norlin et al. (2005) Abbreviations: Con A, concanavalin A; NK cells, natural killer cells; TNF-a, tumor necrosis factor-a.
Knockout and transgenic models for NF-jB pathway S Gerondakis et al et al., 2002) , the finding that BAFF also activates p50 dimers (Hatada et al., 2003) indicates that p50 may contribute to BAFF-dependent B-cell survival. nfkb1
À/À follicular B cells also display proliferative defects when treated with particular mitogens. Whereas BCRmediated proliferation is normal in nfkb1 À/À B cells, these cells respond poorly to the toll-like receptor (TLR)-4 ligand lipopolysaccharide (LPS) (Sha et al., 1995) , exhibiting a partial block in G-to S-phase cellcycle progression and enhanced death (Grumont et al., 1998) . These B-cell-intrinsic activation defects extend to isotype switching (Snapper et al., 1996) , which can partly account for the impaired humoral immune responses displayed by nfkb1 À/À mice (Sha et al., 1995) . In the T-cell lineage, nfkb1 is dispensable for thymocyte maturation (Sha et al., 1995) , but is required to generate normal Th2 responses involving the effector cytokines interleukin (IL)-4, IL-5 and IL-13 (Das et al., 2001; Artis et al., 2005) . This defect is due in part to a failure of nfkb1 À/À dendritic cells (DC) to promote Th2 differentiation (Artis et al., 2005) . A role for p50/p105 in the formation of Th1 cells remains unclear. One study has reported that it is dispensable for generating Th1 effectors and interferon g (IFN g) expression 'in vitro' (Das et al., 2001) , whereas another found that the loss of p50/p105 led to impaired clonal expansion of antigenspecific CD4
þ Th1 effectors and defective cytokine production (Artis et al., 2003) .
Loss of p50/p105 also disrupts innate immune function. The induced expression of the immune effectors IL-6, IL-10 and Cox-2 in nfkb1 À/À macrophages is markedly reduced when these cells are stimulated with TLR ligands (Sha et al., 1995; Waterfield et al., 2003; Banerjee et al., 2006) . Consistent with the Cox-2 and IL-6 genes being regulated by both NF-kB and ERKdependent transcription factors, the impaired expression of these genes in nfkb1 À/À macrophages was found to result from a combined deficiency in both the NF-kB and ERK pathways (Waterfield et al., 2003; Banerjee et al., 2006) . Activated nfkb1 À/À natural killer (NK) cells, on the other hand, display enhanced proliferation and increased IFNg production in culture and 'in vivo' when challenged with Toxoplasma gondii, suggesting that nfkb1 is a negative regulator of NK cell function (Tato et al., 2006) .
With nfkb1 À/À mice displaying these multifocal immune defects, not surprisingly it has proven difficult to predict the outcome when they are subjected to microbial challenge. For example, nfkb1 À/À mice are highly susceptible to Leishmania major (Artis et al., 2003) , Listeria monocytogenes and Streptococcus pneumoniae (Sha et al., 1995) , they respond normally to Haemophilus influenza and Escherichia coli (Sha et al., 1995) , but are more resistant to encephalomyocarditis virus (Sha et al., 1995) . nfkb1-dependent susceptibility to particular pathogens can even be extended to differences between particular organs (O'Donnell et al., 2005) . Whereas reovirus-induced apoptosis is reduced in the central nervous system of nfkb1 À/À mice, viral replication and cell death are increased in the heart. This latter finding is a direct result of a failure to induce INF-b in heart tissue.
nfkb1
À/À mice also display altered responses in other models of disease and stress. For example, disease severity in different experimental models of arthritis varies markedly. Whereas nfkb1 À/À mice are resistant to collagen-induced arthritis, a CD4 þ T-cell-dependent disease, they remain susceptible to an innate immune model of arthritis (Campbell et al., 2000) . In a study of atherosclerosis, nfkb1 À/À mice fed a high-fat diet exhibit smaller atherosclerotic plaques that contain fewer foam cells, a phenotype that coincides with reduced uptake of oxidized low-density lipoprotein by nfkb1 À/À macrophages (Kanters et al., 2004) . nfkb1 À/À mice have also been found to be more sensitive to wholebody irradiation-induced lethality, a result of increased apoptosis of intestinal epithelial cells . Finally, nfkb1 À/À mice are resistant to the muscle atrophy that occurs during unloading of muscle mass (Hunter and Kandarian, 2004) .
DCT/DCT mice. Targeted deletion of the p105 C-terminal ankyrin repeats, which leads to elevated levels of nuclear p50 homodimers, confirms the importance of the C terminus as a regulatory domain. Animals homozygous for this mutation (nfkb1 DCT/DCT ) exhibit splenomegaly, enlarged lymph nodes and lymphoid infiltrates in various organs (Ishikawa et al., 1998 ). An increase in the number of B cells is accompanied by hyperresponsiveness to mitogens. Activated nfkb1
DCT/DCT
T cells, however, exhibit a diminished proliferative capacity and produce reduced amounts of cytokines. Although these mice display a heightened susceptibility to various pathogens, ascribing their reduced immunity to a specific defect is difficult owing to their complex B-and T-cell immune phenotype.
NF-kB p52/p100
The NF-kB subunit p52, derived from the N terminus of the p100 precursor by signal-induced proteolytic cleavage, is the major dimer partner of RelB. The expression of p52 is highest in hemopoietic tissues, where it is required for the development of secondary lymphoid structures, B-cell maturation, plus normal T-cell and antigen presenting cell (APC) function. These functions, mediated by TNF-R superfamily ligands, induce the production of p52 dimers by promoting the IKKadependent phosphorylation and subsequent proteolytic processing of p100.
nfkb2
À/À mice. An absence of p52/p100 is compatible with embryonic development and adult viability, but nfkb2 À/À mice display a range of immune defects that include a failure to develop normal secondary lymphoid structures, impaired B-lymphocyte maturation and abnormal T-cell function (Beinke and Ley, 2004) . nfkb2 À/À mice exhibit disruption of splenic and lymph node architecture that includes an absence of the splenic perifollicular marginal zone and a marked depletion of B-cell follicular areas (Caamano et al., 1998; Franzoso et al., 1998) . Similar defects are also present in mice lacking lymphotoxinb (LTb), lymphotoxin b-receptor (LTbR), NF-kB-inducing kinase (NIK) or RelB (Beinke and Ley, 2004) . These shared phenotypes led to the identification of a signalling pathway operating downstream of LTbR, which in stromal cells are required for the p52/RelB-dependent expression of stromal cell-derived factor (SDF), Epstein-Barr virus-induced molecule 1 (EBI-1) and B lymphocyte chemoattractant (BLC), chemokines that are crucial for lymphoid organogenesis (Bonizzi et al., 2004) . In addition to LTb, other TNF-R superfamily ligands that include CD40, BAFF, TWEAK and RANK ligand, all induce the nuclear expression of p52/RelB dimers via the NIK-IKKa-dependent processing of p100 (Beinke and Ley, 2004) . Consequently, the defects that occur in mice lacking these p52/RelB-inducing ligands are likely to overlap with those seen in nfkb2 À/À mice. One such example is the impaired B-cell survival seen in mice that lack BAFF or nfkb2 (Gerondakis and Strasser, 2003) . The reduced numbers of mature peripheral B cells in nfkb2 À/À mice (Franzoso et al., 1998) and to an even greater extent in mice lacking BAFF (Yan et al., 2001) are due to diminished survival resulting from impaired Bcl-2 expression that normally is partially nfkb2-dependent (Claudio et al., 2002) . Despite this mature B-cell defect, the proliferation and antibody production by the remaining nfkb2 À/À B cells when these cells are activated in culture appears relatively normal (Franzoso et al., 1998) .
The role of p52/p100 in T-cell responses is complex. In culture, activated nfkb2 À/À T cells proliferate normally and cytokine expression is not impaired (Franzoso et al., 1998) . However, Th1 responses mounted by nfkb2 À/À mice differ markedly when challenged with different pathogens. nfkb2 À/À mice are highly susceptible to Leishmania major owing to an inability to develop a normal IFNg response (Speirs et al., 2002) . This is not due to an intrinsic failure of nfkb2 À/À T cells to develop a Th1 phenotype, rather it results from impaired CD40-dependent IL-12 production by nfkb2 À/À macrophages. Although increased susceptibility of nfkb2 À/À mice to T. gondii is also due to the defective production of IFNg, this instead results from a Fas-dependent reduction in T-cell numbers (Caamano et al., 2000) . The finding that p100 is a negative regulator of RelB function in DC is also likely to have consequences for adaptive immune responses (Speirs et al., 2004) . nfkb2 À/À DC, which have increased RelB activity, display an enhanced ability to induce CD4 þ T-cell responses that coincides with increased major histocompatibility complex class II and co-stimulatory molecule expression.
DCT/DCT mice. Like the nfkb1 DCT/DCT mice (Ishikawa et al., 1998) , targeted deletion of the p100 C-terminal ankyrin repeats reveals their importance as an inhibitory domain. Mice homozygous for this C-terminal deletion (nfkb2 DCT/DCT ) develop a wide range of postnatal pathologies that include gastric hyperplasia, hyperkeratosis in the heart and spleen, lymphocytic infiltrates of various tissues, enlarged lymph nodes and granulocytosis (Ishikawa et al., 1997) . These hyperproliferative defects, which afflict a wide range of tissues and cell types, are consistent with the induction of p52-containing dimers being regulated by a multitude of TNF-R family ligands (Beinke and Ley, 2004) . Because the p100 C terminus normally functions as a negative regulatory domain, affected tissues from nfkb2 DCT/DCT mice not unexpectedly express higher than normal levels of p52 dimers and display increased expression of certain genes known to be targets of NF-kB signalling. The deregulated growth of gastric epithelium and the enhanced lymphocyte proliferation seen in nfkb2 DCT/DCT mice emphasize the importance of regulating cellular proliferation by keeping a tight reign on the nuclear levels of p52 dimers. A role for p52 in promoting cell proliferation is further supported by the discovery that some human lymphomas have NFKB2 gene alterations akin to the targeted C-terminal deletion created in nfkb2
DCT/DCT mice (Courtois and Gilmore, 2006) .
c-Rel
The highest levels of c-Rel are expressed in lymphocytes, myelomonocytic cells and erythroid cells in both fetal and adult hemopoietic organs, an expression pattern that reflects its importance in immune function Liou and Hsia, 2003) . However, the recent findings that c-Rel is expressed at low levels in the epidermis and its appendages and is involved in epidermal keratinocyte function (Gugasyan et al., 2004) suggest that other non-hemopoietic functions for this transcription factor remain to be discovered.
c-rel
À/À mice. Although c-Rel is dispensable for hemopoietic progenitor cell differentiation (Ko¨ntgen et al., 1995) , like NF-kB p50/p105, c-Rel is essential for the normal function of B and T cells, macrophages and DC. In the B-cell lineage, c-Rel coordinates cell-cycle progression and the survival of mature B cells in response to diverse mitogenic signals through the control of distinct target genes. c-Rel appears to promote G1-to S-phase cell-cycle progression (Grumont et al., 1998) by inducing the expression of E2F3a (Cheng et al., 2003) , whereas c-Rel-promoted B-cell survival is dependent on upregulating the Bcl-2-like prosurvival genes A1 and bcl-XL Cheng et al., 2003) . Isotype switching is also impaired in c-rel À/À B cells (Pohl et al., 2002) , although the extent to which defects in germline CH gene transcription and cell division each contribute to this defect remains unclear.
Despite being expressed at different stages of thymocyte development, c-Rel is dispensable for positive and negative selection (Strasser et al., 1999) . It does however control CD4
þ and CD8 þ T-cell immunity through a combination of T-cell autonomous and non-autonomous mechanisms. During CD4 þ T-cell responses, c-Rel regulates Th1 development plus quantitative and qualitative aspects of cytokine expression in response to microbial challenge (Mason et al., 2004) , in pathogenic models of CNS inflammation (Hilliard et al., 2002) , in streptozotocin-induced type I diabetes Knockout and transgenic models for NF-jB pathway S Gerondakis et al (Lamhamedi-Cherradi et al., 2003) and during islet allograft rejection (Yang et al., 2002) . Whereas c-Reldependent production of IL-12 by professional APC, such as DC (Grumont et al., 2001) , has been shown to be important in skewing the development of Th1 responses in experimentally induced EAE (Hilliard et al., 2002) , c-Rel function is dispensable for generating Th1 cells and APC-dependent production of IL-12 when challenged with T. gondii (Mason et al., 2004) . Instead, the impaired Th1 response seen in c-rel À/À mice infected with T. gondii appears to result from T-cell-intrinsic defects associated with the defective clonal expansion of Th1 effector cells (Mason et al., 2004) . c-Rel function is also important for regulating the T-cell-dependent production of cytokines. In CD4 þ T cells, c-Rel is required for proinflammatory cytokine priming of immune responsiveness that leads to faster and greater production of IFNg and IL-2 by naı¨ve but not effector T cells (Banerjee et al., 2005) . During CD4 þ T-cell activation, c-Rel is required for the efficient production of IL-2 and granulocyte-macrophage colony-stimulating factor (GM-CSF) (Gerondakis et al., 1996) , which in the case of IL-2 involves c-Rel directly regulating IL-2 transcription by controlling chromatin remodelling across the IL-2 promoter (Rao et al., 2003; Chen et al., 2005) .
Consistent with the findings demonstrating that c-Rel regulation of CD4 (Hilliard et al., 2002) and CD8 (Mintern et al., 2002) immune responses is mediated in part through its control of APC function, c-Rel serves a number of roles in different APC. c-rel À/À mice have reduced numbers of plasmacytoid DC (pDC) (O'Keeffe et al., 2005) , the major producers of type I IFNs. An absence of c-Rel does not affect conventional DC (cDC) development or the expression of co-stimulatory proteins on mature cDC (O'Keeffe et al., 2005) , but c-Rel is necessary for these cells both to promote antigen-specific CTL responses by a mechanism of antigen crosspriming (Mintern et al., 2002) and to induce transcription of the IL-12 p35 gene (Grumont et al., 2001) . This latter finding contrasts with a c-Rel requirement for p40 IL-12 subunit expression by macrophages (Sanjabi et al., 2000) . The reason why c-Rel-dependent regulation of the subunits that comprise IL-12 differs for particular APC is unclear, but it is tempting to speculate that it may be linked to cDC and macrophages serving as the critical sources of IL-12 in primary and sustained immune responses, respectively. Similar findings for the c-Rel-dependent cell-type-specific control of GM-CSF, inducible nitric oxide synthase and G-CSF have also been documented (Gerondakis et al., 1996; Grigoriadis et al., 1996) . In the case of GM-CSF, whereas c-Rel is required for its transcription in T cells (Gerondakis et al., 1996) , it functions as a repressor of GM-CSF transcription in resident peritoneal macrophages but is dispensable for GM-CSF production by elicited peritoneal macrophages . These distinct roles are likely to reflect differences in the modification of c-Rel or its interaction with other proteins in particular cell types.
Aside from a role in promoting neuronal survival (Pizzi et al., 2002 (Pizzi et al., , 2005 , c-Rel has also been implicated in long-term memory (LTM) formation. Consolidation of LTM requires N-methyl-D-aspartate receptor-dependent changes in gene expression. Using a bioinformatic approach, c-Rel binding sites were found to be enriched in the upstream region of genes regulated during consolidation of LTM. This involvement of c-Rel in hippocampus-dependent LTM formation was confirmed in gene expression studies using c-rel À/À mice (Levenson et al., 2004) .
DCT/DCT mice. Targeted removal of the C-terminal region of c-Rel, which contains the transactivation domain, leads to mice developing a complex phenotype of immune dysfunction that includes hypoplastic bone marrow, splenomegaly, enlarged lymph nodes and lymphoid hyperplasia (Carrasco et al., 1998) . This truncated c-Rel protein is able to form dimers and bind DNA, but, like its viral counterpart v-Rel, is unlikely to be able to regulate the normal program of transcription.
c-Rel transgenic mice. Transgenic mice with v-rel under the control of the T-cell-specific LCK promoter develop T-cell leukemia/lymphoma (Carrasco et al., 1996) , whose appearance can be delayed by crossing these mice to transgenic mice overexpressing IkBa . These results and an overwhelming body of other evidence support the notion that deregulated c-Rel expression is oncogenic; yet, it has proven difficult to establish mouse models in which c-rel functions as an oncogene (Gilmore et al., 2004) . The exception is transgenic mice in which c-Rel expression is under the transcriptional control of the hormoneresponsive MMTV promoter (Romieu-Mourez et al., 2003) . These mice develop mammary tumors after a long latency, with the expression of NF-kB target genes cyclin D1, c-myc and bcl-XL all elevated in the mammary carcinomas. The finding that misregulated c-Rel expression can contribute to murine mammary tumorigenesis is consistent with its overexpression in human breast cancers (see Baldwin, 2006) . Of note, my lab has been unable to generate transgenic mice with c-rel under the control of a B-cell-specific promoter, suggesting that overexpression of c-Rel may be toxic at some stage of B-cell development (S Gerondakis, unpublished observations).
RelA
The RelA subunit of NF-kB is ubiquitously expressed and rapidly activated in many cell types in response to inflammatory and immune mediators. To date, a detailed description of the in vivo function of RelA has been somewhat limited by the embryonic lethality of rela À/À embryos at BE14-E15 (Beg et al., 1995b) .
The absence of RelA in knockout mice leads to embryonic death resulting from extensive tumor necrosis factor (TNF)a-mediated fetal hepatocyte apoptosis (Beg et al., 1995b) . Disrupting TNF signalling, either by removing TNFa (Doi et al., 1999) or TNF-R1 (Alcamo et al., 2001) , prevents this hepatocyte apoptosis Knockout and transgenic models for NF-jB pathway S Gerondakis et al in rela À/À mice, allowing embryonic development to proceed through to birth. That is, rela
À/À mice are born at the expected frequency and exhibit no gross abnormalities, indicating that aside from serving a protective role against TNF-induced toxicity during development, the absence of RelA is tolerated throughout mouse embryogenesis. However, following birth, rela
À/À mice exhibit elevated levels of post-natal death that is thought to result from increased susceptibility to microbial infections (Alcamo et al., 2001) .
In addition to preventing TNFa-mediated hepatocyte apoptosis, RelA protects a number of other cell types including macrophages (Beg and Baltimore, 1996) , B cells (Prendes et al., 2003) and T cells (Senftleben et al., 2001 ) from the TNF toxicity. However, this antiapoptotic role for RelA is not restricted to exposure to TNF, given that RelA also protects cells from cell death induced by double-stranded RNA, a TLR-9 ligand . The antiapoptotic function of RelA involves the regulation of multiple target genes that encode proteins such as c-FLIP, cIAP1, cIAP2, A20, GADD45b, MnSOD and ferratin heavy chain (Ge´linas, 2006) .
RelA also serves multiple roles in the immune system. For example, RelA is involved in generating secondary lymphoid organs, as a disruption of splenic architecture and an absence of lymph nodes is seen in rela (Alcamo et al., 2002) . Using radiation chimeras, it was found that the role of RelA in the formation of secondary lymphoid organs is dependent on radioresistant stromal cells rather than the hemopoietic compartment. In conjunction with NF-kB p50, RelA serves to reduce sensitivity to LPS-induced toxic shock mediated by the innate immune system (Gadjeva et al., 2004) . RelA is essential for leukocyte recruitment during the initiation of innate immune responses (Alcamo et al., 2001) , it is necessary for T-cell-dependent responses (Alcamo et al., 2002) and rela À/À B cells exhibit impaired isotype switching to IgG3 that is associated with a decrease in Cg3 germline gene expression (Horwitz et al., 1999) .
RelA is also necessary for the normal function of the nervous system and skin. In the central nervous system, p50/RelA heterodimers (NF-kB) and NF-kB p50 homodimers are the main proteins expressed in neurons, Schwann cells and glia (Meffert and Baltimore, 2005) . In neurons, NF-kB is activated in response to excitatory neurotransmitters via a Ca 2 þ -responsive pathway that involves Ca 2 þ /calmodulin-dependent protein kinase II (CaMKII), which has been shown to be important for long-term adaptive responses in neurons. Consistent with this biochemical link, when rela
À/À mice were subjected to learning performance studies using a maze, it was found that RelA is required for the learning of spatial information (Meffert et al., 2003) . In the skin, it has been proposed that RelA is a negative regulator of epidermal homeostasis . Hyperproliferation in the epidermis lacking NF-kB function (Seitz et al., 1998) was shown to coincide with increased rela À/À keratinocyte proliferation in culture, a phenotype linked to the failure to inhibit TNFa-mediated keratinocyte division .
RelB
RelB is unique among NF-kB proteins in that it cannot form homodimers, instead regulating transcription as p52/RelB and p50/RelB heterodimers. High levels of RelB are restricted to specific regions of the thymus, lymph nodes and Peyer's patches. Consistent with this expression pattern, its prime role appears to be one of promoting the formation of secondary lymphoid structures and regulating the development and function of certain cell types involved in immune responses.
relb
À/À mice. Mice with a targeted disruption of relb develop a complex inflammatory phenotype and hematopoietic abnormalities (Burkly et al., 1995; Weih et al., 1995) . Mouse relb knockout pathologies include T-cell inflammatory infiltrates of multiple organs, T-celldependent myeloid hyperplasia, splenomegaly resulting from extramedullary hemopoiesis and inflammatory dermatitis. Although the underlying basis of the inflammatory phenotype remains to be determined, it is thought to involve impaired regulatory T-cell function resulting from a combination of stromal and hemopoietic defects (Thomas, 2005) .
Mice lacking RelB, like those missing its dimer partners p50 or p52, exhibit defects in secondary lymphoid structures (Weih et al., 2001; Yilmaz et al., 2003) . relb À/À mice lack Peyer's patches and fail to form splenic germinal centers and follicular DC (FDC) networks in response to antigen challenge. RelB is also required for organization of the marginal zone and its population by macrophages and B cells (Weih and Caamano, 2003) . Whereas RelB expression in radiationresistant stromal cells is necessary for proper formation of germinal centers, FDC networks and marginal zone structures, the generation of marginal zone B cells is dependent upon RelB expression in hemopoietic cells (Weih et al., 2001) . Like the defects in lymphoid organogenesis that occur in nfkb2 À/À mice, those seen in animals lacking RelB are associated with the impaired p52/RelB-dependent expression of homing chemokines regulated by LTb signalling (Bonizzi et al., 2004) .
RelB has been shown to serve an important role in DC function. relb À/À mice lack certain thymic and splenic DC populations, a phenotype that is thought to result from a combination of impaired stromal function and defects intrinsic to hemopoietic precursors (Wu et al., 1998) . RelB function in DC is also necessary for T-cell activation by conventional priming (Zanetti et al., 2003) that occurs through direct processing and presentation of soluble antigen taken up from the microenvironment, and by crosspriming (Castiglioni et al., 2002; Zanetti et al., 2003) , which involves the processing and presentation of antigen released from other cells.
RelB is also required for the normal development and function of T-lineage cells. In the thymus, the generation of early NK1.1
À natural killer T cell (NKT) precursors is dependent on RelB expression in radiation-resistant thymic stromal cells (Elewaut et al., 2003; Sivakumar et al., 2003) , whereas T-cell-intrinsic expression of RelB is necessary for the proliferation and survival of single positive thymocytes during the final stages of development (Guerin et al., 2002) . In mature CD4 þ T cells, RelB is required for normal Th1 function and IFNg production, with impaired Th1 differentiation of relb À/À T cells linked to a decrease in Stat4 expression (Corn et al., 2005) .
Given the multitude of defects in relb À/À mice in the stromal and hemopoietic compartments, not surprisingly, a range of immune responses that include delayed hypersensitivity, CD4 Th1 function, CD8 cytotoxicity, macrophage-mediated immunity to various pathogens and IgG responses to T-cell-dependent antigens are impaired (Weih et al., 1997; Caamano et al., 1999; Corn et al., 2005) . The humoral defects seen in these knockout mice are likely the result of impaired CD4 þ T-cell responses owing either to a defect in APC or T-cell function itself, given that relb À/À B-cell function in culture appears relatively normal (Weih et al., 1997) .
Mice lacking multiple NF-jB transcription factors
Although null mutations for the individual NF-kB transcription factors reveal their unique roles, overlapping expression patterns and redundant functions shared by NF-kB proteins most likely mask the emergence of certain phenotypes in the single mutant mice. Indeed, this conclusion is supported by findings that mice lacking multiple NF-kB proteins exhibit novel phenotypes or more severe versions of those seen in the individual knockouts.
À/À mice A combined absence of p50/p105 and p52/p100 does not disrupt embryogenesis; however, following birth, nfkb1
À/À mice are growth retarded and exhibit cranofacial abnormalities owing to osteopetrosis that arises from a combination of defects in the hemopoietic compartment plus the bone marrow environment (Franzoso et al., 1997b; Iotsova et al., 1997) . Although nfkb1
À/À mice have reduced numbers of myeloid lineage-derived osteoclasts (Franzoso et al., 1997b) , the combined function of p50 and p52 is not required to generate RANK-expressing osteoclast progenitors, but instead is essential for these precursors to differentiate into TRAP (tartrate-resistant acidic phosphatase)-positive osteoclasts in response to RANK ligand and other cytokines (Xing et al., 2002) .
A recent analysis of nfkb1 À/À nfkb2 À/À mice reveals a combined role for these transcription factors in coordinating the LTb-dependent formation of secondary lymphoid organs. Notably, the defects in lymph node formation and splenic architecture seen in nfkb1 À/À and nfkb2 À/À mice are not as severe as those documented in mice lacking the LTbR, with the ltbr À/À phenotype recapitulated only in nfkb1
2006). Consistent with this genetic analysis, LTb induces the nuclear expression of both p50-and p52-containing dimers. NF-kB p50 and p52 also cooperate to promote B-cell maturation: nfkb1 À/À nfkb2 À/À mice lack marginal zone B cells and mature follicular B cells, with only sIgM þ CD21 À B cells present in the spleen and lymph nodes (Franzoso et al., 1997b) , lymphocytes that represent the most recent emigrants from the bone marrow. This defect in follicular B-cell differentiation arises from a failure of immature nfkb1
À/À B cells to undergo survival-dependent maturation, which is normally driven by BAFF-induced Bcl-2 expression (Claudio et al., 2002) .
À/À mice The combined absence of p50/p105 and RelB exacerbates the severity and extent of organ inflammation that occurs in the absence of RelB (Weih et al., 1997) . Although myeloid hyperplasia is increased in these double knockouts, unlike the inflammatory infiltrates seen in relb À/À mice, those infiltrates in mice lacking both p50 and RelB are devoid of B cells, the result of a defect in B-cell development.
nfkb1
À/À c-rel À/À mice The combined functions of p50/p100 and c-Rel are dispensable for embryonic development and are compatible with adult mouse viability (Pohl et al., 2002) . Although hemopoiesis appears normal, these double knockout mice exhibit immune defects that are more severe than those seen in the individual mutant mice.
The diminished CD5
þ peritoneal B-cell population in nfkb1 À/À mice is further reduced in the nfkb1 c-rel À/À cDC, which coincides with enhanced apoptosis in cell culture models of DC differentiation (Ouaaz et al., 2002) , can be overcome 'in vivo' either by promoting development in a normal stromal environment or enforced Bcl-2 transgene expression in the hemopoietic compartment (O'Keeffe et al., 2005) . This indicates that p50 and c-Rel function cooperatively to generate cDC populations through the stromal promotion of cDC survival. In the case of pDC, by using bone marrow chimeras and Bcl-2 transgenic mice, it was found that the roles of p50 and c-Rel in generating a normal-sized cell population involves a combination of DC-intrinsic and environmental cues linked to survival-dependent and survival-independent mechanisms (O' Keeffe et al., 2005) . Both p50 and c-Rel are also required for the maturation of pDC activated by specific TLR signals (O'Keeffe et al., 2005) . Unlike wild-type, c-rel À/À or nfkb1 À/À pDC, all of which are able to undergo morphological transformation when activated through TLR-9, nfkb1 À/À c-rel À/À pDC instead undergo enhanced cell death owing to an inability to upregulate antiapoptotic A1 and Bcl-XL gene expression and fail to acquire a DC phenotype. Although enforced Bcl-2 expression prevents the TLR-9-induced apoptosis, it fails to overcome the block in pDC morphogenesis, indicating that p50 and c-Rel cooperatively promote pDC survival and differentiation through the regulation of distinct targets.
The cell activation defects afflicting nfkb1
B cells are more severe than those seen in the single mutant mice Pohl et al., 2002) . Activation-induced apoptosis is markedly elevated in these double knockouts, and unlike the impaired G1-to S-phase transition observed in mitogen-stimulated c-rel À/À and nfkb1 À/À single knockout B cells (Grumont et al., 1998) , those lacking both transcription factors fail to undergo blast formation or cell growth, a defect characteristic of impaired G0-to-G1 progression . This growth defect was shown to result from an inability to induce c-myc transcription . Defects in humoral immunity and splenic architecture seen in nfkb1 À/À and c-rel
single knockout mice are also exaggerated in the double mutant (Pohl et al., 2002) . nfkb1
þ T-cell responses that coincide with defects in the post-thymic development of CD4 þ effector, memory and regulatory T cells . Although nfkb1
cells exhibit impaired cell-cycle entry and increased apoptosis in response to CD3 or CD3 plus CD28 engagement, nfkb1
À/À c-rel À/À T cells still undergo mitogen-induced growth , indicating that these transcription factors serve different cell-cycle roles in B and T cells. The increased apoptosis of activated nfkb1 À/À c-rel À/À T cells was found to coincide with a failure to upregulate Bcl-XL via a TCR-induced survival pathway .
nfkb1
À/À rela À/À mice The absence of p50/p105 and RelA results in embryonic death owing to TNF-mediated hepatocyte apoptosis at an earlier embryonic stage (BE13) than that seen in rela À/À mice (Horwitz et al., 1997) . Irradiated mice receiving E12 nfkb1 À/À rela À/À fetal liver hemopoietic progenitors exhibit defects in myelopoiesis and B-cell development (Horwitz et al., 1997) . The block in B-cell development occurs at a point in lymphopoiesis that precedes the formation of B220 þ cells. The ability to generate B cells in culture from nfkb1 À/À rela À/À hemopoietic progenitors, coupled with this early developmental block being overridden by simultaneous engraftment of wild-type progenitors, indicates that this defect is extrinsic to the B-cell lineage. Despite normal hemopoietic cells being able to rescue the development of nfkb1 À/À rela À/À B cells, these cells fail to divide in response to mitogenic signals (Horwitz et al., 1999) , revealing a combined role for p50 and RelA in the control of mature B-cell activation. (Grossmann et al., 1999) . Studies investigating the roles of these transcription factors in hemopoiesis indicate that c-Rel and RelA are necessary for the normal development of multiple hemopoietic lineages (Grossmann et al., , 2000 . rela À/À c-rel À/À hemopoietic progenitors engrafted into lethally irradiated mice have high numbers of nucleated erythrocytes, a phenotype consistent with a failure to switch from primitive to definitive erythropoiesis . These engrafted mice, like those receiving nfkb1 À/À rela À/À hemopoietic progenitors (Horwitz et al., 1997) , also exhibit a systemic expansion of granulocytic cells and a reduction in monocytes . Consistent with this phenotype resulting from an imbalance in myelopoiesis, monocyte but not neutrophil differentiation in culture is blocked and accompanied by apoptosis . The development of peripheral lymphoid populations is also impaired in the combined absence of RelA and c-Rel. rag-1 À/À mice engrafted with rela À/À c-rel À/À fetal liver hemopoietic progenitors have markedly reduced numbers of mature B cells, the result of an inability of immature rela À/À c-rel À/À B cells newly emerged from the bone marrow to undergo further differentiation (Grossmann et al., 2000) . This maturation defect, which coincides with a failure to upregulate expression of the prosurvival proteins A1 and Bcl-2, can be largely overcome by Bcl-2 transgene expression. This indicates that these transcription factors induce peripheral B-cell maturation by promoting survival (Grossmann et al., 2000) . The reduction in peripheral rela
T cell numbers appears to be unrelated to survival (Grossmann et al., 2000) and instead may be the result of a defect in peripheral rela À/À c-rel À/À T-cell expansion. Consistent with such a model, rela À/À c-rel À/À T cells exhibit a severe cell-cycle block early in G1 resulting from a failure to undergo c-Myc-dependent cell growth .
Blocking the embryonic death of rela À/À c-rel À/À double knockout mice by inactivating TNF signalling has revealed additional roles for these transcription factors. Although the development of rela
À/À embryos proceeds through to birth, newborn mice die within 12 h from unknown causes (Gugasyan et al., 2004) . These mice are smaller than littermate controls but show no gross developmental defects. A detailed analysis of development in rela À/À c-rel À/À tnfa À/À embryos has revealed that these transcription factors are essential for the normal development of epidermal structures (Gugasyan et al., 2004) . In contrast to the normal skin structures seen in c-rel
À/À embryos exhibit multiple epidermal defects that include a failure to form specific hair types, disorganized basal keratinocyte architecture and thinner skin. The thinner epidermis appears to result from fewer keratinocytes in the basal layer undergoing division, a defect that is due to delayed G1 cell-cycle progression. Yet despite this defect, rela À/À c-rel
tnfa À/À keratinocytes are still able to undergo terminal differentiation and generate a cornified layer. With RelA expression being ubiquitous, the finding that c-Rel is normally expressed in hair follicle cells and basal layer keratinocytes, the same structures that are disrupted in the skin of rela
À/À mice, indicates that the combined roles served by these transcription factors during skin differentiation are autonomous to these cells. In addition to these roles in embryonic skin, c-Rel and RelA control skin homeostasis in newborn mice by suppressing the recruitment and activation of the innate and adaptive immune systems (Gugasyan et al., 2004) . This phenotype, which shares many features in common with the inflammatory skin conditions observed in mice with a keratinocyte-specific deletion of IKKb (Pasparakis et al., 2002a) or female mice heterozygous for an inactive allele of NEMO (Schmidt-Supprian et al., 2000) , indicates that c-Rel and RelA appear to be the transcriptional mediators of this mechanism of immune suppression regulated by the IKKb/NEMO pathway.
IKK proteins
The kinase complex that induces the nuclear translocation of canonical NF-kB transcription factors by phosphorylating IkB proteins is comprised of two closely related catalytic subunits, IKKa and IKKb, and a non-catalytic regulatory subunit, NEMO (aka IKKg), which is essential for kinase activity. Alternatively, the induction of the p100/RelB-p52/RelB non-canonical pathway is induced by activation of a homodimer of IKKa, which contains neither IKKb nor NEMO (see Gilmore, 2006; Scheidereit, 2006) .
IKKa
The IKKa subunit of the IKK complex serves both NF-kB-dependent and NF-kB-independent functions. Its major role in regulating the NF-kB pathway involves the signal-dependent phosphorylation of p100, a step that is necessary to initiate the proteolytic processing of p100 required to generate p52-containing dimers (Hayden and Ghosh, 2004) , which among other things are essential for the normal development of lymphoid organs. During inflammation, IKKa also serves a nuclearspecific role in NF-kB-dependent gene expression by modifying chromatin structure through phosphorylation of histones (Anest et al., 2003; Yamamoto et al., 2003) . In contrast to these NF-kB-dependent roles in the immune system, in the skin IKKa serves an NF-kB-independent function. ikka À/À and ikk AA/AA mice. The complexities of IKKa function first came to light through the generation of ikka À/À mice. Mutants lacking IKKa exhibit a striking set of morphological defects that afflict skeletal and epidermal development Li et al., 1999a; Takeda et al., 1999) . A lack of concordance between the phenotype of the ikka À/À mutant and mice lacking single or multiple NF-kB transcription factors remained unexplained until it was shown that the skin defects observed in ikka À/À mice are independent of IKKa kinase activity or NF-kB activation (Cao et al., 2001; Hu et al., 2001) . Using a catalytically inactive allele of IKKa (IKK AA ) in which serine residues 168 and 172 in the kinase activation loop are substituted for alanine residues, mice homozygous for the IKK AA allele (ikk AA/AA ) are viable and in contrast to ikka À/À mice display none of the skin and bone defects (Cao et al., 2001 ). Surprisingly, when a keratinocyte-specific IKKa transgene was introduced onto the ikka À/À background, in addition to rescuing the skin defects, these mice displayed none of the bone abnormalities (Sil et al., 2004) . This reversal of the skeletal abnormalities indicates that IKKa function in the epidermis also controls bone morphogenesis. Although the pathway by which IKKa regulates skin and bone development remains to be identified, it was found that the expression of fibroblast growth factor (FGF) family members such as FGF8 is elevated in the limb bud ectoderm of ikka À/À mice (Sil et al., 2004) . This led to the proposal that IKKa may regulate skin and bone development by repressing FGF gene expression.
The generation of mice lacking catalytically active IKKa (ikk AA/AA ) has enabled the investigation of NF-kBdependent IKKa function in a number of tissues and cell types. For example, this model has revealed that IKKa is required for lactation and lobuloalveolar development during pregnancy (Cao et al., 2001) . Although ductal development is normal in virgin ikk AA/AA females, following the birth of offspring, the mammary gland lobuloalveolar network remains underdeveloped, and is characterized by a reduction in the number and size of secretory alveoli. This mammary gland autonomous defect does not appear to be the result of a differentiation block, rather it is associated with impaired mammary epithelial cell proliferation that coincides with reduced cyclin D1 expression.
Consistent with an essential role for IKKa in the phosphorylation-dependent processing of p100, ikk AA/AA mice, like those lacking nfkb2, exhibit defects in lymphoid organogenesis, germinal center formation and the generation of mature FDC (Bonizzi et al., 2004) . Using bone marrow chimeras, the role of IKKa in FDC formation and splenic architecture was shown to be stromal cell-dependent, mediated through the production of chemokines such as BLC, EBI-1, secondary lymphoid-tissue chemokine (SLC) and SDF-1, all of which are regulated in part by p52/RelB dimers (Bonizzi et al., 2004) . The similarity in the defects afflicting lymphoid organ architecture that are shared by mice lacking LTb, NIK, IKKa or NF-kB2 highlights the biochemical link involving LTb induction of p100 processing through the NIK-dependent activation of IKKa.
In addition to its role in sculpting the immune system through stromal cell function, IKKa also serves hemopoietic cell-intrinsic roles in controlling development and function in the innate and adaptive arms of the immune system. In the B-cell lineage, IKKa is essential for normal B-cell development (Kaisho et al., 2001; Pasparakis et al., 2002b) . Bone marrow chimeras reconstituted with ikka À/À fetal liver hemopoietic progenitors lack mature recirculating sIgM lo IgD hi B cells. Consistent with this phenotype arising from a failure to Knockout and transgenic models for NF-jB pathway S Gerondakis et al support the survival of mature B cells, the immature ikka À/À B cells in these chimeras exhibit increased turnover and heightened levels of apoptosis (Kaisho et al., 2001) . This defect reflects a requirement for elevated Bcl-2 transcription in mature B cells, which is dependent on the BAFF-induced expression of p52 (Claudio et al., 2002) . ikk AA/AA mice exhibit a heightened inflammatory response to infections . This enhanced capacity to clear bacteria has been linked to the macrophages from these mice displaying increased bacteriocidal functions that include greater phagocytic activity, enhanced antigen presentation and increased proinflammatory gene expression. Consistent with the increased inflammatory response by ikk AA/AA macrophages, these mice are more sensitive to septic shock. Although these enhanced macrophage functions coincide with increased NF-kB activity, the underlying mechanism accounting for the augmented NF-kB response remains unclear. It was reported that the increased levels of inflammatory mediators that are produced by LPS-stimulated ikk AA/AA macrophages are the result of sustained promoter occupancy by c-Rel and RelA, which under normal circumstances are targeted for proteolysis when phosphorylated by IKKa . However, ikka À/À macrophages were also reported to show a decreased post-induction of IkBa that was linked to enhanced IkBa phosphorylation and degradation caused by hyperactivity of the IKK complex .
IKKb
The IKKb kinase component of the IKK complex activates RelA, c-Rel and p50-containing dimers in response to a wide variety of stress-associated signals (see Scheidereit, 2006) . In keeping with its essential role in this process, loss of IKKb function in different cell types, like that seen in mice lacking various NF-kB transcription factors, results in the impaired regulation of cell survival, immune function and inflammation (Karin and Delhase, 2000; Li and Verma, 2002; Karin and Lin, 2002) . ikkb À/À mice and conditional IKKb knockouts. An absence of IKKb leads to mouse embryonic death at BE13 (Li et al., 1999; Li et al., 1999b; Tanaka et al., 1999) . As with rela À/À knockout mice, this death results from TNFa-induced hepatocyte apoptosis that can be blocked by inhibiting TNFa/TNF-R1 signalling (Li et al., 1999b) , a finding that reflects the weak TNFa induction of NF-kB in ikkb À/À cells (Li et al., 1999b; Tanaka et al., 1999) . Seemingly normal liver development in ikkb
À/À embryos establishes that aside from this antiapoptotic role, IKKb serves no other essential functions in this organ during embryogenesis (Li et al., 1999b) .
The embryonic lethality of ikkb À/À mice has forced researchers to study IKKb function through the use of conditional knockouts. In keeping with the capacity of NF-kB to inhibit or promote apoptosis, loss of IKKb function has similar outcomes, which depend on the type of stress and the tissue involved (Graham and Gibson, 2005) . For example, whereas conditional knockouts have shown that IKKb protects macrophages , osteoclasts (Ruocco et al., 2005) and gut epithelium (Chen et al., 2003) from apoptosis triggered by TLR signals, IKKb is required for neuronal apoptosis induced by ischemic brain injury (Herrmann et al., 2005) . While a detailed account of the role played by IKKb in cell survival is dealt with elsewhere in this edition (Ge´linas, 2006) , the specific ablation of IKKb in hepatocytes helps illustrate the nuances of NF-kB antiapoptotic function in adult mice. NF-kB continues to serve an antiapoptotic role in adult hepatocytes by countering TNF-induced damage that arises during inflammation-induced pathology associated with LPS, concanavalin A or D-galactosamine treatment (Schwabe and Brenner, 2006) . Importantly, hepatocyte-specific inactivation of IKKb reveals the ability of NF-kB to confer protection against TNF, which is dictated by its mode of signalling. Whereas mice lacking IKKb in hepatocytes are resistant to liver damage that results from administering recombinant TNFa or LPS, which induces the synthesis of soluble TNF, these mice remain sensitive to concanavalin A, which promotes hepatocyte apoptosis by triggering signalling through membrane-bound TNF (Maeda et al., 2003) . The failure of LPS to induce apoptosis in IKKb-deficient hepatocytes is supported by the finding that NF-kB is still activated, albeit at reduced levels, in the IKKb-deficient cells by soluble TNF (Luedde et al., 2005) . This indicates that unlike ikkb À/À embryonic fibroblasts, which are sensitive to apoptosis induced by soluble TNFa, in ikkb À/À hepatocytes IKKa can inhibit TNF-induced apoptosis by inducing NF-kB. Why IKKb/NF-kB is able to protect hepatocytes from soluble but not membrane-bound TNF remains unclear, but raises the intriguing possibility that soluble and membrane-bound TNF trigger apoptosis through distinct signalling pathways.
A different relationship between NF-kB and TNF signalling in the liver has been revealed by experiments involving partial hepatectomy in mice. Following liver resection, hepatocytes undergo a pronounced proliferative response that coincides with the induction of TNF expression and the rapid activation of NF-kB. The importance of TNF in this process is underscored by impaired liver regeneration and a failure to induce NF-kB in tnfr1 À/À mice (Yamada et al., 1997) . Despite NF-kB function in the liver having been shown to be required for hepatocyte proliferation following hepatectomy (Iimuro et al., 1998) , surprisingly inhibition of NF-kB function in hepatocytes does not prevent their proliferation (Chaisson et al., 2002) . Instead, experiments that involved the conditional deletion of IKKb in hepatocytes or resident hemopoietic cells of the liver such as macrophage-like Kupffer cells established that hepatocyte proliferation was only dependent on activating NF-kB in the hemopoietic compartment of the liver (Maeda et al., 2003 . This finding establishes that it is the NF-kB-dependent production of TNF by non-parenchymal liver cells that promotes the growth of hepatocytes.
The role of IKKb in regulating inflammatory responses is dictated by the cell types involved. For example, IKKb is crucial for the production of various inflammatory cytokines by macrophages , it is involved in inflammation-induced bone loss (Ruocco et al., 2005) and it has been implicated in the inflammatory component of obesityinduced insulin resistance (Arkan et al., 2005) . In the case of the link between inflammation and obesityinduced diabetes, conditional deletion of IKKb in different mouse tissues reveals the importance of NF-kBdependent myeloid inflammatory responses in this disease (Arkan et al., 2005) . Whereas hepatocyte-specific inactivation of IKKb resulted in the liver retaining insulin responsiveness, muscle and fat tissue still became insulin-resistant in mice receiving a high-fat diet. However, mice with a myeloid-specific inactivation of IKKb retained systemic sensitivity to insulin, indicating that the NF-kB-dependent production of inflammatory mediators by myeloid cells is central to the development of systemic insulin resistance associated with type II diabetes. Similar conclusions were reached by targeting the expression of a conditionally active allele of IKKb to hepatocytes (Cai et al., 2005) . Unlike hemopoietic cells, maintaining IKKb function in keratinocytes inhibits inflammation (Pasparakis et al., 2002a) . Conditional deletion of IKKb in keratinocytes does not disrupt skin development during embryogenesis, but shortly after birth these mice develop a severe inflammatory skin disease. Pathology is characterized by keratinocyte hyperproliferation associated with immune infiltration and increased cytokine expression, all of which are dependent on TNFa expression (Pasparakis et al., 2002a) . The finding that inactivating the canonical NF-kB pathway in keratinocytes triggers inflammation is in contrast to the role of IKKb/NF-kB in hemopoietic cells such as monocytes, where it is essential for the inflammatory process. This seemingly counterintuitive role of NF-kB in keratinocytes as a negative regulator of innate immune activation may reflect a need for the skin as the first line of defense against infection to counter those microorganisms able to inactivate NF-kB in hemopoietic cells of the immune system (Gugasyan et al., 2004) .
Finally, the conditional deletion of IKKb in lymphoid cells confirms its importance in mature B-and T-cell populations. Similar to the findings made in rela À/À c-rel À/À and nfkb1 À/À c-rel À/À mice (Grossmann et al., 2000; Pohl et al., 2002) , in B-lineage cells, IKKb is dispensable for early B-cell development but is crucial for the maintenance of mature splenic follicular and marginal zone B-cell populations (Pasparakis et al., 2002b; Li et al., 2003) . In the T lineage, although conditional targeting of IKKb does not prevent the development of naı¨ve T cells, NKT and CD4 þ CD25 þ regulatory T cells are absent (Schmidt-Supprian et al., 2004) , indicating that the canonical NF-kB pathway is required for the development or maintenance of specific T-cell subsets.
Transgenic mice expressing constitutively active IKKb. Deregulated overexpression of NF-kB has been documented for a number of diseases, in particular cancer (Baldwin, 2006) . To investigate the consequences of continuous NF-kB signalling, researchers have generated transgenic mice that express a constitutively active IKKb allele in which serine residues 177 and 181 have been substituted with the phosphoserine mimetic, glutamic acid (IKKb SS/EE ), which results in NF-kB being induced in a stimulus-independent cell autonomous fashion. To date, the pathogenic consequences of constitutive NF-kB activation arising from the tissuespecific expression of IKKb SS/EE have been documented in skeletal muscle which undergoes wasting (Cai et al., 2004) , a finding that complements studies performed in nfkb1 À/À and bcl3 À/À mice (Hunter and Kandarian, 2004) . This experimental strategy has also been exploited to investigate the developmental roles of NF-kB. For example, targeted expression of IKKb SS/EE to the T-cell lineage has revealed that NF-kB promotes thymocyte survival at a specific stage in T-cell ontogeny that precedes TCR rearrangement (Voll et al., 2000) .
NEMO
The NEMO protein lacks kinase activity and instead serves a regulatory role that is essential for activation of the canonical NF-kB pathway (Scheidereit, 2006) .
and conditional nemo knockout mice. nemo À/À mice, like those lacking IKKb, die during embryogenesis from TNF-induced hepatocyte apoptosis, although their death occurs earlier at BE10-E11 (Rudolph et al., 2000) . Because the nemo gene is located on the X chromosome, female mice heterozygous for the inactive allele, although viable, have tissues that are mosaic for an absence of NEMO function. These mice develop an inflammatory skin disease following birth that is very similar to humans with incontinentia pigmenti (Makris et al., 2000) , a genetic condition that is caused by NEMO mutations (see Courtois and Gilmore, 2006) .
Using radiation chimeras reconstituted with nemo À/À fetal liver hemopoietic progenitors, B-and T-lineage cells fail to develop . Although this suggests that NEMO is important in progenitors committed to the lymphoid lineages, the ability to generate IgM þ B cells from nemo À/À embryonic stem cells in an 'in vitro' differentiation system shows that intrinsic expression of NEMO is dispensable for the development of immature B cells . These immature nemo À/À IgM þ B cells, like ikka À/À and ikkb À/À B cells, exhibit enhanced apoptosis. Targeted deletion of nemo in the T lineage, while reducing the number of CD8 þ but not CD4 þ thymocytes, results in a complete absence of peripheral T cells (SchmidtSupprian et al., 2003) , establishing an essential requirement for NEMO in the maintenance of mature T lymphocytes.
Knockout and transgenic models for NF-jB pathway S Gerondakis et al
IjB proteins
The temporal and spatial expression of NF-kB dimers is largely regulated by the three IkB proteins, IkBa, IkBb and IkBe. Although the preferential affinity of specific IkB isoforms for select NF-kB dimers, coupled with the nuclear-cytoplasmic shuttling of NF-kB by some IkB proteins, contributes to NF-kB regulation, it is primarily the differences in IkB degradation and re-syntheses that determine the major functional characteristics of IkBs (Hoffmann et al., 2002) . Indeed, when the IkBb coding region was introduced into the ikba locus, NF-kB was regulated in a manner similar to that of wild-type mice , indicating that the regulatory properties of IkBa and IkBb appear to be very similar.
ikbe À/À mice Given that deficiencies in NF-kB function can have a wide range of physiological consequences (see above), it is not surprising that deregulated and increased NF-kB activity is also detrimental. This is best illustrated in mice lacking IkBa. Although the gross embryonic development of ikba À/À mice is relatively normal, these mice die within 7-10 days of birth, afflicted by a severe widespread inflammatory dermatitis and a markedly amplified granulocytic compartment (Beg et al., 1995a; Klement et al., 1996) . Consistent with the importance of IkBa in regulating the NF-kB-dependent expression of inflammatory mediators, the dermatitis in ikba À/À mice is associated with the enhanced expression of TNF, G-CSF, MIP-2 and eotaxin (Klement et al., 1996) . Whereas deregulated expression of inflammatory mediators enhances the recruitment and prolongs the survival of neutrophils, the presence of increased numbers of myeloid progenitors in ikba À/À mice indicates that granulopoiesis may also be deregulated. Using radiation chimeras reconstituted with fetal liver hemopoietic progenitors, coupled with the conditional removal of IkBa in the hemopoietic compartment, the myeloproliferative phenotype seen in ikba À/À mice was determined not to be myeloid cell autonomous (Rupec et al., 2005) . Instead, the expansion of myeloid progenitors was driven by the continuous deregulated perinatal expression of the NF-kB-dependent target gene Jagged-1 in ikba À/À hepatocytes, a finding that indicates that myeloid hyperplasia can be initiated by constitutive NF-kB signals in non-hematopoietic cells.
Attention has also focused on whether deregulated NF-kB activity unleashed through the loss of IkB proteins perturbs lymphocyte development and function. Avoiding the complications associated with the perinatal lethality arising from a systemic absence of IkBa, B-and T-cell development was found to be normal in rag2 À/À mice reconstituted with ikba À/À fetal liver hemopoietic progenitors (Chen et al., 2000) . However, in response to mitogenic signals, the proliferation of ikba À/À B cells is enhanced, whereas that of ikba À/À T cells is reduced, findings that indicate that different levels of NF-kB are necessary during lymphocyte activation for optimal proliferation in B versus T cells (Chen et al., 2000) . Unlike the ikba À/À mutant, ikbe À/À mice are viable and display only subtle defects in the immune system that include an increased expression of certain Ig isotypes and cytokines (Memet et al., 1999) .
In keeping with the likelihood that IkB function is largely redundant in the lymphoid lineage, the combined absence of IkBa and IkBe leads to a severe disruption in lymphopoiesis . In ikba (Samson et al., 2004) . A deficiency in IkBa or IkBe has no major effect on NK cell generation, yet their combined absence (which leads to NF-kB hyperactivation) results in reduced NK cell numbers, incomplete NK cell maturation and defective IFNg production. Complementary analysis of transgenic mice expressing an NF-kB-responsive reporter showed that NF-kB activity normally increases at the stage of NK cell development, which corresponds to the developmental block observed in ikba À/À ikbe À/À mice, thereby defining a critical window in NK cell development during which NF-kB levels must be tightly controlled.
bcl3
À/À mice Bcl-3, a nuclear IkB originally identified as a candidate proto-oncogene in chronic lymphocytic leukemia, appears to primarily serve as a co-activator of p50 and p52 homodimer-dependent transcription (Hayden and Ghosh, 2004) . In bcl3 À/À mice, splenic architecture is disrupted and germinal center formation is diminished (Franzoso et al., 1997a; Schwarz et al., 1997) . This is accompanied by a reduction in the numbers of follicular B cells and the loss of specific splenic marginal zone macrophage populations. Although Th1 responses to microbial challenge are impaired in bcl3 À/À mice (Franzoso et al., 1997a; Schwarz et al., 1997) , the finding that bcl3 À/À T cells activated in culture produce normal levels of IFNg indicates that the Th1 defects may be linked to impaired APC function. bcl3 À/À T cells also display defects in Th2 differentiation and the production of IL-4, IL-5 and IL-13 (Corn et al., 2005) . This was shown to be associated with a T-cell-intrinsic decrease in GATA-3 transcription factor expression, a finding consistent with evidence that Bcl-3 can transactivate the gata-3 promoter. Phenotypes shared between bcl3 À/À and nfkb2 À/À or nfkb1 À/À mice confirm the biochemical cooperation between Bcl-3 and the p50 and p52 NF-kB subunits for transcription activation. For example, the defects in lymphoid organogenesis seen in bcl3 À/À mice closely resemble those of nfkb2 À/À mice (Franzoso et al., 1997a) ; moreover, both Bcl-3 and p50 are involved in the control of muscle tissue homeostasis (Hunter and Kandarian, 2004) .
Transgenic expression of degradation-resistant IkBa and IkBb isoforms Degradation-resistant IkBa and IkBb mutants (IkBm) that function as dominant inhibitors of NF-kB activation when expressed under the control of tissue-specific or developmentally restricted promoters have been used to probe NF-kB function in a range of cell types in mice, including B (Bendall et al., 1999) and T lymphocytes (Boothby et al., 1997; Esslinger et al., 1997; Attar et al., 1998; Ferreira et al., 1999; Hettmann et al., 1999; Voll et al., 2000; Hettmann and Leiden, 2000) , muscle (Cai et al., 2004) , neurons (Fridmacher et al., 2003) , hepatocytes (Lavon et al., 2000; Cai et al., 2005) , heart (Dawn et al., 2001) , pancreas (Norlin et al., 2005) and skin (Seitz et al., 1998; van Hogerlinden et al., 1999) . Although this approach has been highly successful, IkBm expression targeted to a particular tissue has been documented to generate distinct phenotypes, or a phenotype of varying severity in different transgenic founder lines. These differences may reflect the type of promoter that was used, the site of transgene integration or transgene copy number. The extensive literature covering the use of this approach precludes a detailed description of all the findings. Instead, the use of IkBm transgenes as a means of investigating NF-kB function will be outlined for T cells, keratinocytes and neurons.
Targeting expression of IkBam to the T-cell lineage using the LCK or CD2 promoter has revealed a number of roles for NF-kB during the development and function of these cells. In the thymus, IkBam expression results in increased numbers of double positive (CD4 þ CD8 þ ) thymocytes owing to impaired negative selection (Hettmann et al., 1999) , but more mature CD4 þ and particularly CD8 þ thymocytes are reduced owing to impaired positive selection (Hettmann and Leiden, 2000) . Consistent with NF-kB being required for negative selection, the apoptosis of double positive thymocytes in response to CD3 crosslinking is blocked when IkBam is expressed in these cells (Hettmann et al., 1999) . Thymocyte proliferative responses induced by TCR crosslinking are also impaired in cells expressing IkBam (Boothby et al., 1997; Hettmann et al., 1999) . The number of peripheral T cells, in particular CD8 þ cells, is markedly reduced (Boothby et al., 1997; Hettmann et al., 1999) and their functional responses are impaired, the extent and nature of which appears to be transgene strain dependent. These include reduced proliferation by CD4 þ and CD8 þ T cells (Aune et al., 1999; Mora et al., 2003) , plus defects in the development, expansion and cytokine production by Th1 effectors (Aronica et al., 1999; Aune et al., 1999; Corn et al., 2003) . In turn, these defects have effects on delayed-type hypersensitivity responses, IgG2a production (Aronica et al., 1999) , the clearance of pathogens such as T. gondii (Tato et al., 2003) and allograft rejection (Finn et al., 2001) .
Targeted overexpression of IkBam in the skin using either the Keratin 14 (Seitz et al., 1998 ) or Keratin 5 (van Hogerlinden et al., 1999 promoter results in epidermal hyperplasia that ultimately leads to the formation of squamous cell carcinomas. Although the keratinocyte hyperproliferation was found to be dependent on TNF signalling in both models (Lind et al., 2004; Zhang et al., 2004) , the underlying mechanism by which TNF promotes epidermal proliferation remains unclear. In K5-IkBam transgenic mice, this phenotype is associated with immune infiltrates, the presence of which is also TNF-dependent (Lind et al., 2004) . This association between immune infiltration and epidermal proliferation, which also occurs in mice with a keratinocyte-specific deletion of IKKb (Pasparakis et al., 2002a) , is consistent with an inflammatory model in which immune cell-derived cytokines drive the proliferation of keratinocytes. In contrast, no immune infiltrates were detected in the skin of K14-IkBam transgenic mice (Seitz et al., 1998) , with the investigators instead proposing that the keratinocyte hyperproliferation is the result of TNF-driven proliferation that is normally intrinsically inhibited by RelA .
By placing IkBm under the transcriptional control of a tetracycline-regulated system that is engineered to be expressed in forebrain neurons by using the CaMKIIa promoter, initially it was found that inhibiting NF-kB in these cells resulted in apoptosis following neurotoxic insults (Fridmacher et al., 2003) . These researchers subsequently used this model to explore the relationship between NF-kB and synaptic activity-dependent transcription, which is crucial for long-lasting neuronal plasticity and long-term memory. NF-kB was found to regulate spatial memory formation by controlling the expression of the alpha catalytic subunit of protein kinase A, an important regulator of CREB (cAMP response element binding protein) signalling in this process (Kaltschmidt et al., 2006) .
An alternate strategy for studying the consequences of inhibiting NF-kB function with IkBm involves introducing the coding region of IkBm into the b-catenin locus (Schmidt-Ullrich et al., 2001), thereby placing IkBm expression under the control of an endogenous gene that is ubiquitously expressed. These researchers added an extra level of regulation into this model by incorporating a loxP-flanked transcription termination cassette that normally kept IkBm expression silent. When Cre-mediated excision was used to induce IkBm expression in all tissues, these mice displayed developmental defects in ectodermal structures such as skin, hair follicles and teeth (Schmidt-Ullrich et al., 2001 ) that were similar to those seen in rela embryonic skin (Gugasyan et al., 2004) or animals with a keratinocyte-specific excision of IKKb (Pasparakis et al., 2002a) , these mice fail to develop a keratinocyte hyperproliferative condition or immune infiltrates in the skin (Schmidt-Ullrich et al., 2001) . This difference is most likely accounted for by the crippled immune system of IkBm knock-in mice that results from the systemic loss of NF-kB and reinforces the notion that keratinocyte hyperproliferation observed in mice that lack NF-kB activity in the skin is a result of hemopoietic cell-derived inflammatory signals.
Bcl-3 transgenic mice
Transgenic overexpression of Bcl-3 in the B-lymphoid lineage, although not impairing development, leads to splenomegaly and an accumulation of mature B cells in the lymph nodes, bone marrow and peritoneal cavity (Ong et al., 1998) . This is accompanied by a heightened proliferative response to the crosslinking of surface IgM and the increased expression of certain immunoglobulin isotypes. No lymphoid neoplasms arose in these transgenic animals, confirming that the expansion of B cells that results from deregulated Bcl-3 expression is in itself insufficient to induce leukemia/lymphoma (see Courtois and Gilmore, 2006) .
NF-jB reporter mice
A number of transgenic mice have been generated that allow NF-kB transcriptional activity to be monitored throughout the mouse. The general approach involves placing a multimer of NF-kB binding sites upstream of a minimal promoter linked to a reporter gene, examples of which include b-globin (Lernbecher et al., 1993) , enhanced green fluorescent protein (Magness et al., 2004) , luciferase (Carlsen et al., 2002) and b-galactosidase (Schmidt-Ullrich et al., 1996) . This strategy offers the advantage of being able to monitor NF-kB activity in minor cell populations or in specific cell types within complex organs during development or in adults. These benefits are partially offset by drawbacks that include transgene insertion sites influencing gene expression, the different affinities specific kB elements have for particular dimers possibly not being a true measure of endogenous NF-kB transcriptional activity, plus the inherent stability of reporter molecules such as b-galactosidase or b-globin mRNA not accurately reflecting the dynamic nature of NF-kB activity.
Concluding remarks
It is heartening to note that since the first installment of this review , the use of mouse strains in which the NF-kB pathway has been genetically manipulated has become an indispensable tool for unravelling its physiological roles. Notwithstanding the considerable insight these models have provided into NF-kB function, their use has brought up as many new questions as they have answered. Foremost among the issues the next generation of mouse models will need to tackle are detailed aspects of regulation that include the role that post-translational modifications of NF-kB pathway components have in the activity, stability and interactions with other proteins (see Perkins, 2006) , how NF-kB function in multiple cell types that collectively contribute to a physiological response is coordinated, how NF-kB signalling is integrated with that of other key intracellular pathways in determining biological outcomes and understanding the role of NF-kB in an ever increasing number of diseases as a means of using this information for disease intervention (see Baldwin, 2006; Courtois and Gilmore, 2006) .
